Alterations in platelet secretion differentially affect thrombosis and hemostasis.

Area of Science:

• Hematology
• Molecular Biology
• Vascular Biology

Background:

• Platelet secretion is crucial for hemostasis and thrombosis.
• Vesicle-associated membrane proteins (VAMPs) mediate platelet exocytosis.
• The specific contribution of different VAMPs to platelet function is not fully understood.

Purpose of the Study:

• To genetically manipulate platelet VAMPs (VAMP2, VAMP3, VAMP8) to assess their roles in platelet secretion.
• To determine the quantitative relationship between platelet secretion levels and in vivo hemostasis and thrombosis.

Main Methods:

• Generated genetically modified mice lacking specific VAMPs (VAMP2, VAMP3, VAMP8) in platelets.
• Assessed platelet granule secretion in vitro.
• Evaluated thrombosis using FeCl3-induced arterial injury model.
• Assessed hemostasis using tail transection bleeding model.
• Measured integrin activation, aggregation, spreading, and phosphatidylserine exposure.

Main Results:

• Loss of VAMP8 exacerbated secretion defects caused by VAMP2/VAMP3 deletion.
• Platelet secretion reduction of ~40-50% impaired thrombosis but not hemostasis.
• Greater than 50% reduction in secretion severely impaired both thrombosis and hemostasis.
• VAMP2Δ3Δ8-/- mice showed profuse bleeding and failed to form occlusive thrombi.
• Phosphatidylserine exposure was reduced in VAMP2Δ3Δ and VAMP2Δ3Δ8-/- platelets.

Conclusions:

• Platelet secretion levels directly correlate with the ability to form occlusive thrombi and maintain hemostasis.
• A significant reduction in platelet secretion (>50%) is required to cause hemostatic defects.
• These VAMP-manipulated mouse models are valuable tools for studying platelet function in vascular processes.